Patient’s Whole Genome Reveals Disease Risks, Drug Responses
NIH, National Institute of General Medical Sciences (NIGMS)Scientists evaluated a man’s entire genome sequence for disease risks and unusual drug responses. The analysis incorporated the man’s medical and family history and statistical disease risks. The work demonstrates that whole-genome sequencing might one day play a clinical role, advancing the concept of personalized medicine.